Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prudential Jennison Health Sciences Fund Class B (PHLBX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector. It will invest in securities of issuers among a number of different countries throughout the world, one of which may be the United States. The portfolio managers use fundamental and quantitative analyses to select individual securities, and they may invest more than 5% of the fund's assets in any one issuer. The fund participates in the initial public offering (IPO) market. It is non-diversified.


1 month+4.44% 3 years+28.92%
3 months-7.64% 5 years+25.96%
1 year+9.71% Since inception+15.95%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return+25.96%+20.66%
Expense ratio1.85%1.39%
Risk 5 year sharpe ratio1.361.42
Net assets$3.4B$3.8B
Average market cap$13.4B$35.0B
Average P/E26.824.4
Portfolio turnover57%57%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyPrudential Investments
Fund manager & tenureDavid Chan / 16 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00


U.S. stock77.93%
International stock17.76%
Fixed income1.71%
Top 5 Sectors
Portfolio weighting
Healthcare 97.95%
Consumer service 1.34%
Business service 0.00%
Consumer goods 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BMRN Biomarin Pharmaceutical Inc5.54%
INCY Incyte Corp4.26%
AGN Allergan3.74%
SHPG Shire3.58%
AZN AstraZeneca3.02%
CELG Celgene2.85%
BIIB Biogen2.41%
MDT Medtronic PLC2.41%
ILMN Illumina Inc2.18%
ALXN Alexion Pharmaceuticals Inc2.17%